SE403377B - Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan - Google Patents

Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan

Info

Publication number
SE403377B
SE403377B SE7316586A SE7316586A SE403377B SE 403377 B SE403377 B SE 403377B SE 7316586 A SE7316586 A SE 7316586A SE 7316586 A SE7316586 A SE 7316586A SE 403377 B SE403377 B SE 403377B
Authority
SE
Sweden
Prior art keywords
disposal
therapeutic
procedure
special
analgetic effect
Prior art date
Application number
SE7316586A
Other languages
English (en)
Swedish (sv)
Inventor
R N Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE403377B publication Critical patent/SE403377B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7316586A 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan SE403377B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
SE403377B true SE403377B (sv) 1978-08-14

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (sv) 1972-12-08 1973-12-07 Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7701795A SE417196B (sv) 1972-12-08 1977-02-17 Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
SE7701796A SE428378B (sv) 1972-12-08 1977-02-17 Analogiforfarande for framstellning av droxanderivat

Country Status (27)

Country Link
JP (2) JPS5742633B2 (fr)
AR (3) AR206306A1 (fr)
AT (2) AT330773B (fr)
BE (1) BE808340A (fr)
BG (4) BG22386A3 (fr)
CA (2) CA1014560A (fr)
CH (4) CH605903A5 (fr)
CS (3) CS222209B2 (fr)
CY (1) CY1017A (fr)
DD (3) DD110864A5 (fr)
DE (1) DE2361340C2 (fr)
DK (1) DK134717B (fr)
ES (4) ES421290A1 (fr)
FR (1) FR2209578B1 (fr)
GB (2) GB1455998A (fr)
HK (1) HK60479A (fr)
HU (2) HU168763B (fr)
IE (1) IE40226B1 (fr)
IL (1) IL43773A (fr)
KE (1) KE2976A (fr)
MY (1) MY8000064A (fr)
NL (1) NL7316839A (fr)
PH (2) PH15197A (fr)
SE (3) SE403377B (fr)
SU (4) SU578001A3 (fr)
YU (3) YU36171B (fr)
ZA (1) ZA739207B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (fr) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methodes pour la preparation d'oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
ES444911A1 (es) 1977-09-01
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
NL7316839A (fr) 1974-06-11
CA1014560A (en) 1977-07-26
DD109625A5 (fr) 1974-11-12
SE7701795L (sv) 1977-02-17
ES421291A1 (es) 1976-07-01
ES421290A1 (es) 1976-07-01
YU318473A (en) 1980-09-25
IL43773A (en) 1979-05-31
HU168763B (fr) 1976-07-28
SE7701796L (sv) 1977-02-17
HU168620B (fr) 1976-06-28
CS222209B2 (en) 1983-05-27
IE40226L (en) 1974-06-08
AU6321773A (en) 1975-06-05
FR2209578B1 (fr) 1977-09-02
DE2361340C2 (de) 1983-11-24
JPS5734835B2 (fr) 1982-07-26
ES444716A1 (es) 1977-05-16
DK134717C (fr) 1977-05-31
DD115653A5 (fr) 1975-10-12
GB1455998A (en) 1976-11-17
CS222208B2 (en) 1983-05-27
CH619219A5 (en) 1980-09-15
AR212416A1 (es) 1978-07-14
YU318573A (en) 1981-06-30
DD110864A5 (fr) 1975-01-12
ATA1026173A (de) 1976-01-15
SU587861A3 (ru) 1978-01-05
CH605903A5 (fr) 1978-10-13
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
BG26205A4 (bg) 1979-02-15
CY1017A (en) 1979-11-23
AR206306A1 (es) 1976-07-15
SU663305A3 (ru) 1979-05-15
HK60479A (en) 1979-08-31
ATA1026073A (de) 1975-10-15
BG21409A3 (bg) 1976-05-20
JPS4987680A (fr) 1974-08-22
IL43773A0 (en) 1974-03-14
CA1024150A (fr) 1978-01-10
CH614439A5 (en) 1979-11-30
CS193480B2 (en) 1979-10-31
DK134717B (da) 1977-01-03
MY8000064A (en) 1980-12-31
YU36171B (en) 1982-02-25
BE808340A (fr) 1974-06-07
JPS4987681A (fr) 1974-08-22
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
GB1455997A (en) 1976-11-17
SE428378B (sv) 1983-06-27
AT330773B (de) 1976-07-26
IE40226B1 (en) 1979-04-11
YU109380A (en) 1981-04-30
BG21223A3 (bg) 1976-03-20
SE417196B (sv) 1981-03-02
AT332396B (de) 1976-09-27
KE2976A (en) 1979-07-20
SU578001A3 (ru) 1977-10-25
BG22386A3 (bg) 1977-02-20
PH14923A (en) 1982-01-29
JPS5742633B2 (fr) 1982-09-09
FR2209578A1 (fr) 1974-07-05
AR212012A1 (es) 1978-04-28
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
NO793012L (no) Fremgangsmaate ved fremstilling av benzodiazepinderivater
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE402283B (sv) Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
FI54312B (fi) Foerfarande foer framstaellning av tieno-(2,3-d)pyrimidinderivat med avsoendring av urinsyra i urin utoekande
AR214383A1 (es) Derivados de dialquilfosfanatos
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
AR207750A1 (es) Procedimiento para la preparacion de derivados de benzo o naftofurano
AR201288A1 (es) Derivados de alfa-cianmetansulfonamidobenceno
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE403377B (sv) Forfarande for frastellning av dioxanderivat med terapeutisk, serskilt analgetisk verkan
SE400767B (sv) Forfarande for framstellning av arylpiperazin-derivat av adenin
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
AR195913A1 (es) Procedimiento para la produccion de derivados 6-piperazinilicos de morfantridina y de analogos heterociclicos de la misma
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
AR205097A1 (es) Procedimiento para la elaboracion de nuevos derivados de diazepina
NO144069C (no) Difluorbutyrofenonderivater som er anvendelige for fremstilling av terapeutisk aktive butyrofenonderivater
SE394430B (sv) Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan
AR198505A1 (es) Procedimiento para la elaboracion de nuevos derivados de diazepina